September 30, 2026

Tirzepatide vs. Semaglutide: A Pharmacist's Comparison for Weight Loss

Not sure whether tirzepatide or semaglutide is right for your weight loss goals? Our compounding pharmacists break down the key differences, side effects, dosing, and clinical outcomes.

Tirzepatide vs. Semaglutide: A Pharmacist's Comparison for Weight Loss

If your provider has mentioned both tirzepatide and semaglutide — and you've left the appointment with more questions than answers — you're not alone. These two medications have reshaped the conversation around weight management over the last several years, and patients across West Texas are understandably trying to make sense of what each one does, how they differ, and which might be a better fit for their situation.

We want to be upfront about what this article is and isn't. It is an overview — written to help you understand the clinical landscape so you can have a more informed conversation with your provider. It's not a substitute for that conversation, and it won't tell you which medication you should take. That decision belongs to your prescriber, who knows your full health history. What we can do is break down the science clearly, honestly, and without the noise.

As always, the right choice depends on your individual health history and what your healthcare provider recommends.

What Are Tirzepatide and Semaglutide? (The Quick Version)

Both tirzepatide and semaglutide belong to a class of medications called GLP-1 receptor agonists. GLP-1 — glucagon-like peptide-1 — is a hormone your body naturally produces after eating. It signals your brain that you're full, slows the rate at which your stomach empties, and helps regulate insulin release in response to blood sugar. These medications mimic or amplify that signal.

Semaglutide activates GLP-1 receptors specifically. It's available under brand names including Ozempic (for type 2 diabetes) and Wegovy (for chronic weight management). Wegovy is available as a weekly injection or a daily oral tablet.

Tirzepatide activates two receptor types — both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). This dual mechanism is what sets it apart. It's marketed as Mounjaro for type 2 diabetes and Zepbound for chronic weight management.

Compounded versions of both medications may be available through a licensed compounding pharmacy with a valid prescription from your healthcare provider. We'll come back to that in more detail below.

The Key Differences Between Semaglutide and Tirzepatide

The primary difference between semaglutide and tirzepatide is their mechanism of action. Semaglutide activates GLP-1 receptors only, while tirzepatide activates both GLP-1 and GIP receptors. Clinical trials suggest tirzepatide may produce greater average weight loss, though individual responses vary significantly.

 

Feature

Semaglutide

Tirzepatide 

Receptor targets

GLP-1 only

GLP-1 + GIP (dual agonist)

Brand names (diabetes)

Ozempic

Mounjaro

Brand names (weight mgmt)

Wegovy

Zepbound

Oral form available?

Yes (Wegovy)

No

Injection frequency

Once weekly

Once weekly

FDA-approved for obesity?

Yes (Wegovy)

Yes (Zepbound)

FDA-approved for T2D?

Yes (Ozempic)

Yes (Mounjaro)


Both are injectable medications administered once weekly. Both require a valid prescription from a licensed healthcare provider.

Tirzepatide vs. Semaglutide for Weight Loss: What the Clinical Data Shows

Which is better for weight loss — semaglutide or tirzepatide?

Based on available clinical data, tirzepatide has demonstrated greater average weight loss than semaglutide at their respective maximum approved doses. The SURMOUNT-5 trial — a direct head-to-head comparison published in the New England Journal of Medicine — found that participants taking tirzepatide lost approximately 20.2% of their body weight on average, compared to 13.7% for those on semaglutide. However, both medications produced clinically meaningful weight loss, and individual results varied substantially across both groups.

The SURMOUNT trial series and the STEP trials (which evaluated semaglutide) each represent some of the most rigorous weight management research conducted in recent years. Across the STEP trials, semaglutide at 2.4 mg produced an average weight loss of around 15% of body weight over 68 weeks. Tirzepatide's SURMOUNT-1 trial showed average losses ranging from 15% to 20.9% depending on the dose studied.

Why does semaglutide work for some patients but not tirzepatide — and vice versa?

Individual responses to both medications are shaped by a wide range of factors: genetics, baseline metabolic function, gut hormone levels, starting weight, dose titration, and how consistently the medication is taken alongside lifestyle adjustments. Some patients respond exceptionally well to semaglutide with minimal side effects; others find tirzepatide's dual mechanism produces better appetite suppression for them. There's no universal answer — which is exactly why these decisions need to be made in partnership with a provider who knows your full picture.

Weight loss outcomes are highly individual. Your response will depend on your starting point, dosing, lifestyle factors, and how your body responds to the medication.

Side Effects: What Makes You Less Sick — Semaglutide or Tirzepatide?

What makes you less sick — semaglutide or tirzepatide?

Both medications share a similar side effect profile, with gastrointestinal symptoms being the most commonly reported. Available data suggests that tirzepatide's GI side effects may be somewhat less intense for some patients, though this varies significantly by individual and dose. Neither medication is side-effect-free, and tolerability is an important conversation to have with your prescriber.

The most common side effects reported with both medications include:

  • Nausea (most common, especially during dose escalation)

  • Vomiting

  • Diarrhea

  • Constipation

  • Reduced appetite (often a desired effect for weight management)

  • Fatigue, particularly early in treatment

What are the drawbacks of tirzepatide?

Tirzepatide's primary drawbacks mirror those of semaglutide: GI side effects during the titration phase can be uncomfortable, and not all patients tolerate the medication well at higher doses. Some patients also experience injection site reactions, and — as with semaglutide — there are important contraindications to discuss with your provider, including personal or family history of certain thyroid conditions. Cost and insurance coverage can also be significant barriers for both medications.

A few practical notes from a pharmacist's perspective: taking your injection with food, staying well-hydrated, and eating smaller meals can help reduce nausea during the early weeks of treatment. Avoid high-fat meals shortly after your injection, as they can intensify GI symptoms.

If you're experiencing significant side effects, contact your prescribing provider before making any changes to your medication or dose schedule.

Dosage: How Tirzepatide and Semaglutide Dosing Compares

Semaglutide for weight loss is typically started at 0.25 mg weekly and titrated upward over several months, with a target maintenance dose of 2.4 mg weekly (Wegovy). Tirzepatide begins at 2.5 mg weekly and may be increased incrementally to a maximum of 15 mg weekly. Dosing schedules and titration should always follow your provider's specific instructions.

Here's a general overview of the approved titration schedules:

Semaglutide (Wegovy — weight management):

  1. Weeks 1–4: 0.25 mg/week

  2. Weeks 5–8: 0.5 mg/week

  3. Weeks 9–12: 1.0 mg/week

  4. Weeks 13–16: 1.7 mg/week

  5. Week 17+: 2.4 mg/week (maintenance)

Tirzepatide (Zepbound — weight management):

  1. Weeks 1–4: 2.5 mg/week

  2. Weeks 5–8: 5 mg/week

  3. Further titration up to 10 mg, 12.5 mg, or 15 mg based on tolerability and provider guidance

Both medications are administered as once-weekly subcutaneous injections. Compounded formulations may be prepared at provider-specified doses to support individualized titration plans.

How long does it take to lose 20 lbs on tirzepatide?

There's no single timeline — it depends on your starting weight, dose, adherence, and individual metabolic response. In clinical trials, participants at higher doses of tirzepatide began seeing meaningful weight reduction within the first 4–8 weeks, with the most significant losses occurring over the first 6 months. Losing 20 pounds may take anywhere from 3 to 6 months for some patients; for others, it may take longer. Your provider can help set realistic expectations based on your specific situation.

Can GLP-1 Medications Be Compounded?

In some cases, yes, but it's more limited than it used to be. Compounding may be an option when:

  • The medication is on the FDA's official drug shortage list

  • A patient needs a dose or strength that isn't commercially available

  • A patient needs a formulation that's different from the commercial product, such as one without an ingredient they're sensitive to

In each case, the patient's provider must determine that the compounded medication meets a specific clinical need for that patient. The rules around compounded GLP-1 medications are evolving, and availability can change as federal and state regulations change.

Which One Is Right for You? Questions to Ask Your Provider

This isn't a decision you'll make alone — and it shouldn't be. Your prescriber will weigh your full health picture, including any existing conditions, prior medication responses, and your long-term health goals. What you can do is come to that appointment prepared.

Here are some questions worth bringing to your next conversation:

  1. Based on my health history, am I a better candidate for semaglutide or tirzepatide?

  2. What weight loss outcomes are realistic for someone at my starting point?

  3. How will we manage side effects during the titration phase?

  4. What lifestyle adjustments should I pair with the medication for the best outcomes?

  5. How will we monitor my progress and decide if the dose needs to be adjusted?

  6. What contraindications should I be aware of given my current health conditions or medications?

  7. Is there a clinical reason a commercially available product might not work for me?

  8. Is this medication covered by my insurance, and are there savings programs available?

Once your provider makes a recommendation, our pharmacists are here to answer your questions, walk you through your titration schedule, and make sure you feel confident before you begin.


Frequently Asked Questions

What is the difference between semaglutide and tirzepatide?

Semaglutide is a GLP-1 receptor agonist that mimics the GLP-1 hormone to regulate appetite and blood sugar. Tirzepatide is a dual GLP-1 and GIP receptor agonist, meaning it activates two hormone pathways rather than one. This dual mechanism is the key pharmacological distinction between the two medications.


Which is better for weight loss — semaglutide or tirzepatide?

Clinical trial data, including the SURMOUNT-5 head-to-head trial, suggests tirzepatide may produce greater average weight loss at maximum doses. However, individual responses vary significantly, and both medications have demonstrated meaningful weight loss outcomes. The best option depends on your individual health history, tolerability, and what your provider recommends.


What are the side effects of tirzepatide compared to semaglutide?

Both medications share similar GI side effects — nausea, vomiting, diarrhea, and constipation are most common, particularly during dose escalation. Some clinical data suggests tirzepatide's GI side effect burden may be slightly lower for certain patients, though this varies by individual. Talk to your prescriber about which medication's tolerability profile may be a better fit for you.


Can tirzepatide or semaglutide be compounded?

In some cases, but it's more limited than it used to be, and a provider must determine that a compounded medication meets a specific clinical need. See "Can GLP-1 Medications Be Compounded?" above for details. 


How long does it take to see weight loss results on these medications?

Most patients begin noticing appetite reduction within the first few weeks of treatment. Meaningful weight loss is often observed within the first 3 months, with more significant results accumulating over 6 to 12 months of treatment. Individual timelines vary based on dose, adherence, and lifestyle factors.


The Bottom Line on Tirzepatide vs. Semaglutide

Both tirzepatide and semaglutide represent significant advances in medically supported weight management, with strong clinical evidence behind each. The differences between them — in mechanism, average weight loss outcomes, and side effect profiles — are real and worth understanding. But the most important thing to know is that neither medication is universally better. The right choice is the one that fits your health history, your goals, and your provider's clinical judgment.

At Thornhill's Pharmacy, our pharmacists are here to be part of your care team — not to replace your prescriber, but to support the plan they put in place. If you're exploring compounded weight management options, we'd welcome the conversation.

Schedule a consultation with our team today — or browse our wellness products to explore the supplement options we carry to support your overall health journey.


The information provided is for educational purposes only and is not intended as medical advice. All compounded medications are prepared for specific patients based on a valid prescription from a licensed healthcare provider. Results may vary. Always consult your healthcare provider before starting, stopping, or changing any medication.